ID   ZZUi002-A
AC   CVCL_VE19
SY   Ctrl-fb001-iPSC
DR   hPSCreg; ZZUi002-A
DR   SKIP; SKIP003087
DR   Wikidata; Q54996145
RX   PubMed=29246575;
CC   Problematic cell line: Probably misidentified. This cell line is said to originate from the same individual as ZZUi001-A but the STR profiles of these two cell lines are completely different.
CC   From: Zhengzhou University First Affiliated Hospital; Zhengzhou; China.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29246575
ST   D13S317: 9,14
ST   D19S433: 16.2
ST   D21S11: 31.2,33
ST   D3S1358: 16,18
ST   D5S818: 8,9
ST   D8S1179: 18,19
ST   TH01: 6,9
ST   TPOX: 10
ST   vWA: 18,22
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
RX   PubMed=29246575; DOI=10.1016/j.scr.2017.07.027;
RA   Zhang Y.-M., Zhu J., Dai Y.-Z., Wang L.-Z., Liu R.;
RT   "Development of one control and one tumor-specific induced pluripotent
RT   stem cell line from laryngeal carcinoma patient.";
RL   Stem Cell Res. 25:283-285(2017).
//